Analysts Offer Insights on Healthcare Companies: Purple Biotech (PPBT) and Aligos Therapeutics (ALGS)
Purple Biotech Analyst Ratings
Purple Biotech Analyst Ratings
Promising Phase 2 Results for Purple Biotech's CM24 in Pancreatic Cancer Treatment Bolster Buy Rating
Buy Rating Justified by Purple Biotech's Promising Clinical Data and Market Potential
Purple Biotech Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Purple Biotech, Maintains $10 Price Target
Purple Biotech Analyst Ratings
Purple Biotech Analyst Ratings
Purple Biotech Analyst Ratings
Promising Pipeline Prospects for Purple Biotech: Buy Rating Affirmed Amidst Anticipated Clinical Advancements
Purple Biotech Analyst Ratings
Buy Rating Justified by Promising Phase 1 Results of Purple Biotech's NT219 in SCCHN Treatment
Analysts Offer Insights on Healthcare Companies: Purple Biotech (PPBT) and Sanofi (OtherSNYNF)
Purple Biotech Analyst Ratings
Promising Clinical Trial Results and Accelerated Enrollment Boost Purple Biotech's Buy Rating
HC Wainwright & Co. Maintains Buy on Purple Biotech, Raises Price Target to $9
Purple Biotech Analyst Ratings
H.C. Wainwright Remains a Buy on Purple Biotech (PPBT)
JonesTrading Initiates Coverage On Purple Biotech With Buy Rating, Announces Price Target of $8
No Data
No Data